Arkolith/Insider Trading/CPRX/Form 4

Daly Richard J

President and CEO, DirectorCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Aug 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$474K
Net Open-Market Flow
-$474K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2025Option exercise(M)50K$2.24$112K250K
Aug 26, 2025Sell(S)23K$20.62$474K227K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 26, 2025Option exercise(M)50K—$02.2M

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-25-000300) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for CATALYST PHARMACEUTICALS, INC.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp